中国患者中乙型肝炎病毒相关滤泡性淋巴瘤的独特临床与遗传特征
研究显示24%的中国滤泡性淋巴瘤患者为HBsAg阳性,这些患者较年轻、诊断时组织学分级更高、24个月内疾病进展发生率更高。对109例肿瘤测序发现HBsAg阳性滤泡性淋巴瘤突变负荷增强且遗传谱独特,缺乏IGH/BCL2易位和CREBBP突变等HBsAg阴性滤泡性淋巴瘤标志,转录组类似活化B细胞样亚型,并伴特定免疫微环境特征。
要点
- 24%的中国滤泡性淋巴瘤患者为HBsAg阳性
- HBsAg阳性患者更年轻、组织学分级更高、24个月内进展率更高
- HBsAg阳性滤泡性淋巴瘤缺乏IGH/BCL2易位和CREBBP突变
核心结论
- 慢性HBV感染与B细胞淋巴瘤发生相关,HBV相关滤泡性淋巴瘤可能具有独特细胞起源并代表滤泡性淋巴瘤的独立亚型。
研究设计与样本
- 研究纳入中国滤泡性淋巴瘤患者,检测HBsAg状态并比较HBsAg阳性与阴性患者的临床特征,对109例滤泡性淋巴瘤肿瘤进行基因组测序及转录组分析。
主要发现
- 24%的中国滤泡性淋巴瘤患者为HBsAg阳性。
- 与HBsAg阴性滤泡性淋巴瘤患者相比,HBsAg阳性患者更年轻、诊断时组织学分级更高、24个月内疾病进展发生率更高。
- HBsAg阳性滤泡性淋巴瘤突变负荷增强,优先突变基因包括TNFAIP3、FAS、HIST1H1C、KLF2、TP53、PIM1、TMSB4X、DUSP2、TAGAP、LYN和SETD2,但缺乏HBsAg阴性滤泡性淋巴瘤的标志性改变即IGH/BCL2易位和CREBBP突变。
- 转录组分析显示HBsAg阳性滤泡性淋巴瘤表达特征类似弥漫性大B细胞淋巴瘤的活化B细胞样亚型,涉及IRF4靶基因及NF-κB/MYD88信号通路。
- HBsAg阳性滤泡性淋巴瘤样本中CD8+记忆T细胞、CD4+ Th1细胞和M1巨噬细胞浸润增加,T细胞耗竭基因特征更高。
临床怎么用
- 肿瘤中识别的可靶向遗传/表观遗传改变及其相关肿瘤微环境可能为该亚组患者提供潜在的新治疗途径(作者认为)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatitis B virus (HBV) infection has been associated with an increased risk for B-cell lymphomas. We previously showed that 20% of diffuse large B-cell lymphoma (DLBCL) patients from China, an endemic area of HBV infection, have chronic HBV infection (surface antigen-positive, HBsAg+) and are characterized by distinct clinical and genetic features. Here, we showed that 24% of follicular lymphoma (FL) Chinese patients are HBsAg+. Compared with the HBsAg- FL patients, HBsAg+ patients are younger, have a higher histological grade at diagnosis, and have a higher incidence of disease progression within 24 months. Moreover, by sequencing the genomes of 109 FL tumors, we observed enhanced mutagenesis and distinct genetic profile in HBsAg+ FLs, with a unique set of preferentially mutated genes (TNFAIP3, FAS, HIST1H1C, KLF2, TP53, PIM1, TMSB4X, DUSP2, TAGAP, LYN, and SETD2) but lack of the hallmark of HBsAg- FLs (ie, IGH/BCL2 translocations and CREBBP mutations). Transcriptomic analyses further showed that HBsAg+ FLs displayed gene-expression signatures resembling the activated B-cell-like subtype of diffuse large B-cell lymphoma, involving IRF4-targeted genes and NF-κB/MYD88 signaling pathways. Finally, we identified an increased infiltration of CD8+ memory T cells, CD4+ Th1 cells, and M1 macrophages and higher T-cell exhaustion gene signature in HBsAg+ FL samples. Taken together, we present new genetic/epigenetic evidence that links chronic HBV infection to B-cell lymphomagenesis, and HBV-associated FL is likely to have a distinct cell-of-origin and represent as a separate subtype of FL. Targetable genetic/epigenetic alterations identified in tumors and their associated tumor microenvironment may provide potential novel therapeutic approaches for this subgroup of patients.
引用
- Ren W, Wang X, Yang M, et al. Distinct clinical and genetic features of hepatitis B virus-associated follicular lymphoma in Chinese patients. Blood Adv. 2022. PMID: 35030632. doi:10.1182/bloodadvances.2021006410
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。